ADGRF4 and ADGRL4 as novel prognostic biomarkers and potential therapeutic implications in stomach adenocarcinoma.

Saved in:
Bibliographic Details
Title: ADGRF4 and ADGRL4 as novel prognostic biomarkers and potential therapeutic implications in stomach adenocarcinoma.
Authors: Wang JH; Department of General Surgery, Anshan Central Hospital, Anshan, China., Li MJ; Department of General Surgery, Panjin Central Hospital, No. 32 Liaohe Middle Road, Xinglongtai District, Panjin, China., Zang DD; Department of Pathology, Panjin Central Hospital, Panjin, China., Wang XW; Department of General Surgery, Panjin Central Hospital, No. 32 Liaohe Middle Road, Xinglongtai District, Panjin, China., Huang P; Department of General Surgery, Panjin Central Hospital, No. 32 Liaohe Middle Road, Xinglongtai District, Panjin, China. huangpeng1822@qq.com.
Source: BMC gastroenterology [BMC Gastroenterol] 2026 May 13; Vol. 26 (1). Date of Electronic Publication: 2026 May 13.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X (Electronic) Linking ISSN: 1471230X NLM ISO Abbreviation: BMC Gastroenterol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first